LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1440
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models ; volume:91 ; number:4 ; day:27 ; month:11 ; year:2012 ; pages:513-522 ; date:4.2013
Journal of molecular medicine ; 91, Heft 4 (27.11.2012), 513-522, 4.2013
- Urheber
-
Guerreiro, Patrícia Silva
Huang, Yue
Gysbers, Amanda
Cheng, Danni
Gai, Wei Ping
Outeiro, Tiago Fleming
Halliday, Glenda Margaret
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00109-012-0984-y
- URN
-
urn:nbn:de:101:1-2019101009172559729859
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guerreiro, Patrícia Silva
- Huang, Yue
- Gysbers, Amanda
- Cheng, Danni
- Gai, Wei Ping
- Outeiro, Tiago Fleming
- Halliday, Glenda Margaret
- SpringerLink (Online service)
Ähnliche Objekte (12)
Does A Child Quantity-Quality Trade-Off Exist? Evidence from the One-Child Policy in China
Family Size and Children’s Education: Evidence from the One-Child Policy in China
Constipation and sleep behaviour disorder associate with processing speed and attention in males with Parkinson’s disease over five years follow-up
Models of α-synuclein aggregation in Parkinson’s disease
NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Does A Child Quantity-Quality Trade-Off Exist? Evidence from the One-Child Policy in China
Family Size and Children’s Education: Evidence from the One-Child Policy in China
Constipation and sleep behaviour disorder associate with processing speed and attention in males with Parkinson’s disease over five years follow-up
Models of α-synuclein aggregation in Parkinson’s disease
NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Does A Child Quantity-Quality Trade-Off Exist? Evidence from the One-Child Policy in China
Family Size and Children’s Education: Evidence from the One-Child Policy in China
Constipation and sleep behaviour disorder associate with processing speed and attention in males with Parkinson’s disease over five years follow-up
Models of α-synuclein aggregation in Parkinson’s disease
NME1 Protects Against Neurotoxin-, α-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson’s Disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease